Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D

International Journal of Cancer

Volumn 67, Issue 4, 1996, Pages 547-554

  Van der Stappen, Jos W J ^a   Williams, Ann C ^a   Maciewicz, Rose A ^b,c   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Muscle and Collagen Research Group   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN D;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CULTURE MEDIUM; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; PROTEIN SECRETION;

ADENOCARCINOMA; ADENOMA; BLOTTING, WESTERN; CARCINOMA; CATHEPSIN B; CATHEPSIN D; CELL LINE; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; ENZYME PRECURSORS; HUMANS; HYDROGEN-ION CONCENTRATION; TUMOR CELLS, CULTURED;

EID: 0029840367     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4     Document Type: Article

References (47)

1. BARRETT, A.J., Cathepsin D and other carboxyl proteinases. In: A.J. Barrett (ed.), Proteinases in mammalian cells and tissues, pp. 209-248, North-Holland, Amsterdam (1977).
2. BARRETT, A.J. and KIRSCHKE, H., Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol., 80, (part C) pp. 535-561, Academic Press, New York (1981).
3. BRIOZZO, P., MORISSET, M., CAPONY, F., ROUGEOT, C. and ROCHEFORT, H., In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res., 48, 3688-3692 (1988).
4. BUCK, M.R., KARUSTIS, D.G., DAY, N.A., HONN, K.V. and SLOANE, B.F., Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J., 282, 273-278 (1992).
5. BURNETT, D., ABRAHAMSON, M., DEVALIA, J.L., SAPSFORD, R.J., DAVIES, R.J. and BUTTLE, D.J., Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch. Biochem. Biophys., 317, 305-310 (1995).
6. BUTTLE, D.J., ABRAHAMSON, M., BURNETT, D., MORT, J.S., BARRETT, A.J., DANDO, P.M. and HILL, S.L., Human sputum cathepsin B degrades proteoglycan, is inhibited by α2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem. J., 276, 325-331 (1991).
7. CHAN, S.J., SAN SEGUNDO, B., MCCORMICK, M.B. and STEINER, D.F., Nucleotide and predicted amino acid sequence of cloned human and mouse preprocathepsin B cDNAs. Proc. nat. Acad. Sci. (Wash.), 83, 7721-7725 (1986).
8. DENHARDT, D.T., GREENBERG, A.H., EGAN, S.E., HAMILTON, R.T. and WRIGHT, J.A., Cysteine proteinase cathepsin L expression correlates closely with the inetastatic potential of H-ras transformed murine fibroblasts. Oncogene, 2, 55-59 (1987).
9. EECKHOUT, Y. and VAES, G., Further studies on the activation of procollagenase, the latent precursor of bone collagenase: effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J., 166, 21-31 (1977).
10. ERICKSON, A.H., Biosynthesis of lysosomal endopeptidases. J. cell Biochem., 40, 31-41 (1989).
11. FELLEISEN, R. and KLINKERT, M-O., In vitro translation and processing of cathepsin B of Schistosoma mansoni. EMBO J., 9, 371-377 (1990).
12. GAL, S. and GOTTESMAN, M.M., The major excreted protein of transformed fibroblasts is an activable acid-protease. J. biol. Chem., 261, 176-1765 (1986).
13. GIESELMANN, V., HASILIK, A. and VON FIGURA, K., Processing of human cathepsin D in lysosomes in vitro. J. biol. Chem., 260, 3215-3220 (1985).
14. GRIFFITHS, J.R., Are cancer cells acidic? Brit. J. Cancer, 64, 425-427 (1991).
15. GUINEC, N., DALET-FUMERON, V. and PAGANO, M., Quantitative study of binding of cysteine proteinases to basement membranes. FEBS Lett., 308, 305-308 (1992).
16. HANEWINKEL, H., GLÖSSL, J. and KRESSE, H., Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J. biol. Chem., 262, 12351-12355 (1987).
17. JAMES, M.N.G. and SIELICKI, A.R., Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8 Angstrom resolution. Nature (Lond.), 319, 33-38 (1986).
18. KAWABATA, T., NISHIMURA, Y., HIGAKI, M. and KATO, K., Purification and processing of rat liver procathepsin. Brit. J. Biochem., 113, 389-394 (1993).
19. KEPPLER, D., WARIDEE, P., ABRAHMSON, M., BACHMANN, D., BERDOZ, J. and SORDAT, B., Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim. biophys. Acta, 1226, 117-125 (1994).
20. KOBAYASHI, H., SCHMITT, M., GORETZKI, L., CHUCHOEOWSKI, N., CALVETE, J., KRAMER, M., GÜNZLER, W.A., JÄNICKE, F. and GRAEFF, H., Cathepsin B efficiently activates the soluble and the tumour cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA). J. biol. Chem., 266, 5147-5152 (1991).
21. LAH, T.T., BUCK, M.R., HONN, K.V., CRISSMAN, J.D., RAO, N.C., LIOTTA, L.A. and SLOANE, B.F., Degradation of laminin by human tumour cathepsin B. Clin. exp Metastasis, 7, 461-468 (1989).
22. LARSEN, L.B., BOISEN, A. and PETERSEN, T.E., Procathepsin D cannot autoactivate to cathepsin D at acid pH. FEBS Lett., 319, 54-58 (1993).
23. LETO, G., GEBBIA, N., RAUSA, L. and TUMMINELLO, F.M., Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res., 12, 235-240, (1992).
24. LENARCIC, B., KRASOVEC, M., RITONJA, A., OLAFSSON, I. and TURK, V., Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS. Lett., 280, 211-215 (1991).
25. LIOTTA, L.A., RAO, C.N., and WEWER, U.M., Biochemical interactions of tumour cells with the basement membrane. Ann. Rev. Biochem., 55, 1037-1057 (1986).
26. MACH, L., MORT, J.S. and GLÖSSL, J., Maturation of human procathepsin B. J. biol. Chem., 269, 13030-13035 (1994).
27. MACH, L., SCHWIHLA, H., STUWE, K., ROWAN, A.D., MORT, J.S. and GLÖSSL, J., Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. Biochem. J., 293, 437-442 (1993).
28. MACH, L., STUWE, K., HAGEN, A., BALLAUN, C. and GLÖSSL, J., Proteolytic processing and glycosylation of cathepsin B: the role of primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme. Biochem. J., 282, 577-582 (1992).
29. MACIEWICZ, R.A. and KNIGHT, P.J., Transmission densitometry of stained nitro-cellulose paper. Anal. Biochem., 175, 85-90 (1988).
30. MACIEWICZ, R.A., WARDALE, R.J., ETHERINGTON, D.J. and PARASKEVA, C., Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int. J. Cancer, 43, 478-486 (1989).
31. MONTCOURRIER, P., MANGEAT, P.H., SALAZAR, G., MORISSET, M., SAHUOUET, A. and ROCHEFORT, H., Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res., 50, 6045-6054 (1990).
32. MURNANE, M.J., SHEAHAN, K., OZDEMIRLI, M. and SHUJA, S., Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res., 51, 1137-1142 (1991).
33. MURPHY, G., ATKINSON, S., WARD, R., GARZILORIC, J. and REYNOLDS, J.J., The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. New York Acad. Sci., 667, 1-12 (1992).
34. MUTO, T., BUSSEY, H.J.R. and MORSON, B.C., The evolution of cancer of the colon and rectum. Cancer, 36, 2251-2270 (1975).
35. NISHIMURA, Y., KAWABATA, T. and KATO, K., Identification of latent procathepsin B and L in microsomal lumen: characterisation of enzymatic activation and proteolytic processing in vitro. Arch. Biochem. Biophys., 261, 64-71 (1988).
36. PARASKEVA, C., BUCKLE, B.G., SHEER, D. and WIGLEY, C.B., The isolation and characterisation of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int. J. Cancer, 34, 49-56 (1984).
37. PERONA, R. and SERRANO, R., Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump. Nature (Lond.), 334, 438-440 (1988).
38. POWERS, J.C. and HARPER, J.W., Inhibitors of serine proteinases. In: A.J. Barrett and G. Salvesen (eds.), Proteinase inhibitors, pp. 55-152. Elsevier, Amsterdam (1986).
39. PYKE, C., KRISTENSEN, P., RALFKIAER, E., ERIKSEN, J. and DANØ, K., The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumour stroma. Cancer Res., 51, 4067-4071 (1991).
40. QIAN, F., BAJKOWSKI, A.S., STEINER. D.F., CHAN, S.J. and FRANKFATER, A., Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res., 49, 4870-4875 (1989).
41. RECKLIES, A.D. and POOLE, A.R., In: L. Weiss and H.A. Gilbert (eds.), Liver metastasis, p. 77, G.K. Hall, Boston (1982).
42. REICH, R., THOMPSON, E.W., IWAMOTO, Y., MARTIN, G.R., DEASON, J.R., FULLER, G.C. and MISKIN, R., Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res., 48, 3307-3312 (1988).
43. RICHO, G. and CONNER, G.E., Proteolytic activation of human procathepsin D, (review) Adv. exp. Med. Biol., 306, 289-296 (1991).
44. ROZHIN, J., SAMENI, M., ZIEGLER, G. and SLOANE, B.F., Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res., 54, 6517-6525 (1994).
45. SLOANE, B.F., LAH, T.T., DAY, N.A., ROZHIN, J., BANDO, Y. and HOHN, K.V., Tumor cysteine proteinases and their inhibitors. In: V. Turk (ed.), Cysteine proteinases and their inhibitors, pp. 729-749, de Gruyter, Berlin (1986a).
46. SLOANE, B.F., ROZHIN, J., JOHNSON, K., TAYLOR, H., GRISSMAN, J.D., and HONN, K.V., Cathepsin B: association with plasma membrane in metastatic tumours. Proc. nat. Acad. Sci. (Wash.), 83, 2483-2487 (1986b).
47. WILLIAMS, A.C., HARPER, B.J. and PARASKEVA, C., Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res., 50, 4724-4730 (1990).